| abstract |
Methods for treating patients for the first time and patients undergoing some treatment suffering from RCC to achieve at least a partial response of the shift that includes administering a therapeutically effective amount of PEG-modified interferon-alpha, for example, interferon alfa 2b, are described. modified with PEG as mono-therapy or associated with a therapeutically effective amount of IL-2. |